India’s online pharmacy market was valued at $3.71 billion in 2025 and is projected to reach $14.08 billion by 2034, growing at a CAGR of 15.98% from 2026 to 2034.Truemeds is an Indian e‑pharmacy and telehealth platform focused on making essential medicines affordable and accessible, especially for patients with chronic conditions. The platform lists a wide range of 2.5 lakh+ products, including prescription (Rx) and over-the-counter (OTC) medicines. It provides clinically approved, high-quality branded substitute medicines at lower costs, empowering users to opt for same-salt or equivalent substitutes prescribed by their doctors.Doctors and pharmacists on Truemeds ensure patients clearly understand the concept of medicine substitution. They educate users about generic alternatives, explaining how these substitutes have the same active ingredient, safety, and effectiveness as the original medicine, but at a lower cost. Through transparent communication, the platform builds trust and empowers users to choose the same salt or an equivalent substitute prescribed by their doctor, if they prefer.Truemeds has helped millions of patients across urban and rural India save on their monthly medicine expenses.In this article, explore more about Truemeds’ founders, business and revenue model, funding, challenges, growth, and more. Company Name Truemeds Headquarters Mumbai, Maharashtra, India Sector E-Pharmacy, Telehealth, Digital Healthcare… Read MoreStartupTalky- Business News, Insights and Stories
